Posted On: 01/27/2015 11:50:29 PM
Post# of 30066
Let's not forget... (It's almost six degrees of separation with AMBS, GC and team connected to, well, almost everything!)
Amarantus CEO Gerald Commissiong Elected to Biotechnology Industry Organization Committees
SAN FRANCISCO and GENEVA, Oct. 20, 2014 (GLOBE NEWSWIRE) -- Amarantus Bioscience Holdings, Inc. (OTCQB:AMBS), a biotechnology company focused on the development of diagnostics and therapeutics for Alzheimer's disease, Parkinson's disease and ophthalmological disorders, announced that President & CEO, Gerald Commissiong, was elected to three Biotechnology Industry Organization("BIO"
committees: the Healthcare Reform & Reimbursement Committee, the Personalized Medicine and Diagnostics Working Group, and the 17th Annual BIO CEO & Investor Conference Advisory Committee.
"BIO is a critical organization that represents the biopharmaceutical industry to work with policy-makers who set guidelines for biotechnology product development and commercial oversight in the United States," said Gerald E. Commissiong, President & CEO of Amarantus. "I'm very happy to become formally involved in this important effort. BIO is the world's largest trade organization representing biotech organizations across the United States and in more than 30 other nations. Its initiatives include improving products, from development to commercialization, which are invaluable to patients in the safest and most efficacious manner possible."
About BIO
BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world's largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIOtechNOW is BIO's blog chronicling "innovations transforming our world" and the BIO Newsletter is the organization's bi-weekly email newsletter." Subscribe to the BIO Newsletter.
http://ir.amarantus.com/company-news/detail/1...committees
Cheers
Amarantus CEO Gerald Commissiong Elected to Biotechnology Industry Organization Committees
SAN FRANCISCO and GENEVA, Oct. 20, 2014 (GLOBE NEWSWIRE) -- Amarantus Bioscience Holdings, Inc. (OTCQB:AMBS), a biotechnology company focused on the development of diagnostics and therapeutics for Alzheimer's disease, Parkinson's disease and ophthalmological disorders, announced that President & CEO, Gerald Commissiong, was elected to three Biotechnology Industry Organization("BIO"
committees: the Healthcare Reform & Reimbursement Committee, the Personalized Medicine and Diagnostics Working Group, and the 17th Annual BIO CEO & Investor Conference Advisory Committee. "BIO is a critical organization that represents the biopharmaceutical industry to work with policy-makers who set guidelines for biotechnology product development and commercial oversight in the United States," said Gerald E. Commissiong, President & CEO of Amarantus. "I'm very happy to become formally involved in this important effort. BIO is the world's largest trade organization representing biotech organizations across the United States and in more than 30 other nations. Its initiatives include improving products, from development to commercialization, which are invaluable to patients in the safest and most efficacious manner possible."
About BIO
BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world's largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIOtechNOW is BIO's blog chronicling "innovations transforming our world" and the BIO Newsletter is the organization's bi-weekly email newsletter." Subscribe to the BIO Newsletter.
http://ir.amarantus.com/company-news/detail/1...committees
Cheers
(0)
(0)
